
You’ve had heel, elbow, knee, shoulder, or hip pain for more than three to six months.
You’ve tried rest, physical therapy, stretching, and anti-inflammatories and still aren’t where you want to be.
You want to avoid cortisone injections, long-term NSAID use, or surgery if a reasonable alternative exists.
You’re an active adult who is tired of modifying workouts around a nagging injury.
You’ve been told the problem is “chronic” or “degenerative” and want to understand what else is possible.
You want a physician-led conversation about your options, not a menu of procedures.
ESWT delivers short-duration, high-pressure acoustic waves into injured soft tissue through a handheld applicator and conductive gel. Each pulse is a mechanical stimulus, not electrical, not thermal, lasting roughly a microsecond.
That mechanical stimulus triggers a biological response called mechanotransduction: cells in and around the treated tissue interpret the pressure as a signal to upregulate their repair pathways.
Research into musculoskeletal applications has observed several downstream effects: increased local microcirculation, modulation of inflammatory signaling, stimulation of growth-factor expression (including VEGF and TGF-β1), recruitment of repair cells, and, in chronic calcific conditions, gradual breakdown of calcium deposits embedded in damaged tendon.
The clinical relevance is straightforward. Chronic tendinopathies often represent stalled healing rather than active injury, tissue that stopped progressing and hasn’t restarted. ESWT provides a controlled mechanical input that can re-initiate repair signaling in tissue that has been quiet for too long.
Two forms are used clinically. Focused shockwaves concentrate energy into a small, deep area. Radial shockwaves disperse energy over a broader, more superficial area. The right choice depends on the tissue involved, where the pathology sits, and the treatment goal.

ESWT has been studied most extensively in chronic tendinopathies and fascial pain. Conditions we may consider it for include:
Candidacy is not determined by symptoms alone. Active infection over the treatment site, open wounds, pregnancy over the treatment area, certain bleeding disorders or anticoagulation requirements, specific cardiac implants, and malignancy in the treatment field are among the reasons we defer or decline treatment. That assessment happens during clinical evaluation, not over the phone.

At Halo, ESWT is not offered as a stand-alone procedure. It is one tool within a broader, physician-led strategy for resolving pain and restoring function, inside and out.
Before we recommend shockwave therapy, we evaluate the full clinical picture: history, relevant imaging, movement assessment, prior treatments, and the systemic factors that may be slowing repair.
In some patients, addressing metabolic and hormonal contributors is what finally allows a long-standing injury to respond. In others, ESWT is what allows eccentric strengthening, progressive loading, and targeted rehabilitation to take hold. Sequencing matters, and we don’t rush it.
A typical treatment runs 15 to 30 minutes start-to-finish. Conductive gel is applied to the skin over the treatment area, and a handheld applicator delivers controlled acoustic pulses for roughly five to fifteen minutes per region.
Most patients describe the sensation as a firm, percussive tapping, uncomfortable at certain intensities, particularly near bony insertions, but generally tolerable without anesthesia. Intensity is adjustable in real time.
There is no recovery downtime. Most patients resume normal activity the same day, though we typically advise against heavy loading of the treated area for 24 to 48 hours.
ESWT is rarely a single-session intervention. The clinical literature most commonly supports a protocol of three to six sessions spaced roughly five to ten days apart.
Some patients notice symptomatic relief within the first week or two, but the tissue-level changes the treatment stimulates unfold over several weeks after the protocol ends. We reassess meaningful progress at eight to twelve weeks post-protocol rather than chasing immediate results, with continued gains possible beyond that window in some cases.
Response varies. Chronic conditions of three to six months’ duration or longer tend to respond more reliably than acute injuries. Published success rates across tendinopathies generally fall in the range of roughly 60% to 80%, depending on the condition, the protocol, and patient-level factors. We discuss realistic expectations at consultation. We do not promise outcomes.
A few clarifications, because this is a space where claims tend to outrun the evidence:
Framed honestly, ESWT is a well-studied mechanical intervention that can meaningfully accelerate repair in the right patient, deployed alongside, not instead of, the rest of the plan
Chronic musculoskeletal pain rarely resolves by repeating what hasn’t worked. If you’ve been living around an injury for months, modifying workouts, reaching for the anti-inflammatories, wondering whether a cortisone shot or surgery is the next step, the right first move is a clinical conversation, not another procedure.
Book a complimentary discovery consult with Halo to discuss whether shockwave therapy, in the context of a broader health and recovery strategy, may be appropriate for you.
Shockwave therapy is generally well tolerated, and serious adverse events are rare in the published literature. Common, self-limiting side effects include mild discomfort during treatment, transient soreness for 24 to 48 hours afterward, minor skin redness, small superficial bruising, and occasional temporary swelling over the treated area.
Contact the clinic if pain that escalates rather than settles after treatment, pronounced swelling lasting beyond 48 hours, skin changes that don’t resolve, or any new symptom you’re uncertain about. Seek urgent care immediately for severe unrelenting pain, signs of infection at the treatment site (spreading redness, warmth, fever), sudden loss of function, numbness, or any symptom that feels clinically concerning.
Most patients describe it as tolerable. Sensation varies with intensity, tissue type, and proximity to bone. treatments over bony insertions like the plantar fascia or Achilles tend to be more intense than those over muscle bellies. Intensity is adjustable throughout the session, and no anesthesia is required.
Protocols typically run three to six sessions spaced five to ten days apart. The exact number depends on the condition, how long it has been present, and how the tissue is responding along the way.
Some patients notice relief within the first week or two. The tissue changes that drive durable improvement unfold over eight to twelve weeks after the final session. We measure progress on that timeline rather than session-by-session.
Light activity is fine. We generally advise against heavy loading of the treated area for 24 to 48 hours and follow a structured reintroduction to training across the treatment course.
Therapeutic ultrasound uses continuous, lower-energy sound waves primarily for localized warming and mild circulatory effects. ESWT delivers brief, high-energy acoustic pulses that create a distinct mechanotransductive response at the cellular level. They are different tools with different mechanisms and different indications.
ESWT is not reliably covered by commercial insurance for most musculoskeletal indications. We discuss cost transparently at consultation so there are no surprises.
Active infection over the site, open wounds in the treatment area, pregnancy over the treatment field, bleeding disorders or anticoagulation requiring specific management, certain cardiac implants, and malignancy in the treatment field are among the reasons we avoid or defer treatment. Candidacy is assessed clinically.
We don’t know until we know. Chronic tendinopathies of three to six months’ duration or longer that have failed conservative care tend to respond more reliably. Acute injuries, underlying systemic drivers, and certain anatomic factors can change the picture. We are candid during evaluation about what the evidence supports for your specific situation
You may also want to read about Joint Health, PRP Therapy, Peptide Therapy, Energy & Recovery, and Longevity & Performance since these areas often overlap with musculoskeletal recovery and the systemic factors that affect tissue repair.
Medically Reviewed By: Halo Concierge Health
Halo Concierge Health is located in Raleigh, NC and serves practice members throughout North Carolina and Virginia. These areas include but are not limited to Raleigh, Wake Forest, Durham, Chapel Hill, Cary, Morrisville, Apex, Holly Springs, Fuquay-Varina, Garner, Clayton, Rolesville, Zebulon, and Mebane with options for follow-up telemedicine appointments.